Single-Cell Analysis Market to be growing at a CAGR of 16.5% by 2021Posted by rohan on September 27th, 2017 The Global Single-Cell Analysis Market was worth USD 1.43 billion in 2016 and estimated to be growing at a CAGR of 16.5%, to reach USD 3.07 billion by 2021. In the field of cellular biology, single-cell analysis consists of the study of genomics, proteomics, metabolomics and so in at the single cell level. Due to the vast differences seen between cells, both prokaryotes and eukaryotes, analysing single cells makes it possible to unveil the mechanisms that could not be seen otherwise. Modern innovations such as Fluorescence-Activated Cell Sorting have increased the efficiency of cell sorting. Other technological advances are increasing our chances to sequence the genome and transcriptome. The applications of studying the genome at a single-cell level include being able to track the changes that occur in bacteria and to study the genetic evolution of cancer. Additional research today in the area has helped biologists to learn more about gene expression profiles in individual cells. The major factors affecting the single-cell analysis market include the increasing geriatric population, high prevalence of infectious diseases and a growing demand for personalized medication. As the health problems, the world faces continue to rise, the demand for research to develop better and efficient medications also rises. This along with the technological advancements in single-cell analysis products is expected to drive the market forward. Inspite of the pros, the market is expected to be hampered by the high-cost of single-cell analysis products and intellectual property rights issues. The Global Single-Cell Analysis market is broadly classified into Consumables such as beads, microplates, reagents, assay kits and others and Instruments such as Flow Cytometers, NGS Systems, PCR instruments and others, on the basis of product and on the basis of cell type they are divided into Human, Animal and Microbial Cells. Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-single-cell-analysis-market-2771/request-sample Furthermore, based on application they are classified into Research Application and Medical Application. Based on technique used, they are classified into Flow Cytometry, NGS, PCR, Microscopy, Mass Spectrometry and Other Techniques. Based on geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. The Single-Cell Analysis Market is dominated by North America in 2016 with the region accounting for 37% of the overall market share. North America was followed next in line by Europe and Asia-Pacific. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. Another promising region for the market is Latin America, which is expected to show high growth rates in coming years. The single-cell analysis market is highly competitive with a large number of players. Some of the major ones are Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General ElectricCompany, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience. About Us: Like it? Share it! More by this author |